BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36445373)

  • 1. Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019.
    Herout R; Baunacke M; Flegar L; Borkowetz A; Reicherz A; Koch R; Kraywinkel K; Thomas C; Groeben C; Huber J
    World J Urol; 2023 Jan; 41(1):127-133. PubMed ID: 36445373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
    BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.
    Matin SF; Sfakianos JP; Espiritu PN; Coleman JA; Spiess PE
    J Urol; 2015 Dec; 194(6):1567-74. PubMed ID: 26094807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Sato G; Yoshida T; Yanishi M; Saito R; Murota T; Kawa G; Kinoshita H; Matsuda T
    Clin Genitourin Cancer; 2020 Apr; 18(2):e167-e173. PubMed ID: 31635939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma.
    Seisen T; Shariat SF; Cussenot O; Peyronnet B; Renard-Penna R; Colin P; Rouprêt M
    World J Urol; 2017 Apr; 35(4):535-548. PubMed ID: 26809456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urothelial Carcinoma of the Renal Pelvis and Ureter: Does Location Make a Difference?
    Lwin AA; Hsu CH; Chipollini J
    Clin Genitourin Cancer; 2020 Feb; 18(1):45-49.e1. PubMed ID: 31786118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative prognostic factors and atypical patterns of recurrence in patients with upper urinary tract urothelial carcinoma treated with laparoscopic radical nephroureterectomy.
    Carrion A; Huguet J; García-Cruz E; Izquierdo L; Mateu L; Musquera M; Ribal MJ; Alcaraz A
    Scand J Urol; 2016 Aug; 50(4):305-12. PubMed ID: 26926709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
    Aboumohamed AA; Krane LS; Hemal AK
    J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.
    Yuan H; Chen X; Liu L; Yang L; Pu C; Li J; Bai Y; Han P; Wei Q
    Urol Oncol; 2014 Oct; 32(7):989-1002. PubMed ID: 25082191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma.
    Sung HH; Jeon HG; Han DH; Jeong BC; Seo SI; Lee HM; Choi HY; Jeon SS
    PLoS One; 2015; 10(11):e0139976. PubMed ID: 26556239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy.
    Ouzzane A; Colin P; Ghoneim TP; Zerbib M; De La Taille A; Audenet F; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M
    World J Urol; 2013 Feb; 31(1):189-97. PubMed ID: 23229227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
    Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
    Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
    Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
    Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
    World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration).
    Katims AB; Say R; Derweesh I; Uzzo R; Minervini A; Wu Z; Abdollah F; Sundaram C; Ferro M; Rha K; Mottrie A; Rosiello G; Simone G; Eun DD; Reese A; Kidd LC; Porter J; Bhattu AS; Gonzalgo ML; Margulis V; Marcus J; Danno A; Meagher M; Tellini R; Mari A; Veccia A; Ghoreifi A; Autorino R; Djaladat H; Mehrazin R
    J Urol; 2021 Sep; 206(3):568-576. PubMed ID: 33881931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Recurrent Renal Cell Carcinoma of the Ipsilateral Ureter Showing Typical Symptoms of Upper Urinary Tract Urothelial Carcinoma: A Case Report and Literature Review.
    Hu M; Pan D; Wei Y; Ye L
    Arch Esp Urol; 2023 May; 76(3):238-244. PubMed ID: 37340529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma.
    Silberstein JL; Power NE; Savage C; Tarin TV; Favaretto RL; Su D; Kaag MG; Herr HW; Dalbagni G
    J Urol; 2012 Feb; 187(2):429-34. PubMed ID: 22177163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Previous or Synchronous Non-Muscle Invasive Bladder Cancer on Clinical Results after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multi-Institutional Study.
    Kim BW; Ha YS; Lee JN; Kim HT; Kim TH; Lee JK; Byun SS; Choi YD; Kang HW; Yun SJ; Kim WJ; Kwon YS; Kwon TG
    Urol J; 2015 Sep; 12(4):2233-9. PubMed ID: 26341764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephroureterectomy vs. segmental ureterectomy of clinically localized, high-grade, urothelial carcinoma of the ureter: Practice patterns and outcomes.
    Piraino JA; Snow ZA; Edwards DC; Hager S; McGreen BH; Diorio GJ
    Urol Oncol; 2020 Nov; 38(11):851.e1-851.e10. PubMed ID: 32859461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma.
    Masson-Lecomte A; Colin P; Bozzini G; Nison L; de La Taille A; Comperat E; Zerbib M; Rozet F; Cathelineau X; Valeri A; Ruffion A; Guy L; Droupy S; Cussenot O; Rouprêt M
    World J Urol; 2014 Apr; 32(2):531-7. PubMed ID: 23907662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.